Compare WLKP & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLKP | OFIX |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.7M | 622.1M |
| IPO Year | 2014 | N/A |
| Metric | WLKP | OFIX |
|---|---|---|
| Price | $20.35 | $14.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 66.5K | ★ 207.0K |
| Earning Date | 02-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 9.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $1,133,706,000.00 | $818,058,000.00 |
| Revenue This Year | $3.88 | $3.97 |
| Revenue Next Year | $12.71 | $5.84 |
| P/E Ratio | $14.57 | ★ N/A |
| Revenue Growth | N/A | ★ 4.31 |
| 52 Week Low | $17.75 | $10.24 |
| 52 Week High | $25.04 | $20.48 |
| Indicator | WLKP | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 72.21 | 36.20 |
| Support Level | $19.07 | $14.72 |
| Resistance Level | $19.98 | $16.42 |
| Average True Range (ATR) | 0.44 | 0.58 |
| MACD | 0.17 | -0.09 |
| Stochastic Oscillator | 99.18 | 5.75 |
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.